Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Firefly Neuroscience (AIFF) over the last 13 years, with Q3 2025 value amounting to 0.05.

  • Firefly Neuroscience's Asset Utilization Ratio rose 18757.26% to 0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05, marking a year-over-year increase of 18757.26%. This contributed to the annual value of 0.09 for FY2023, which is 8666.88% down from last year.
  • According to the latest figures from Q3 2025, Firefly Neuroscience's Asset Utilization Ratio is 0.05, which was up 18757.26% from 0.02 recorded in Q2 2025.
  • Over the past 5 years, Firefly Neuroscience's Asset Utilization Ratio peaked at 3.59 during Q1 2021, and registered a low of 0.0 during Q1 2025.
  • For the 5-year period, Firefly Neuroscience's Asset Utilization Ratio averaged around 0.96, with its median value being 0.78 (2022).
  • Within the past 5 years, the most significant YoY rise in Firefly Neuroscience's Asset Utilization Ratio was 18757.26% (2025), while the steepest drop was 9943.68% (2025).
  • Firefly Neuroscience's Asset Utilization Ratio (Quarter) stood at 0.92 in 2021, then fell by 2.24% to 0.9 in 2022, then increased by 19.31% to 1.07 in 2023, then crashed by 98.4% to 0.02 in 2024, then skyrocketed by 187.57% to 0.05 in 2025.
  • Its last three reported values are 0.05 in Q3 2025, 0.02 for Q2 2025, and 0.0 during Q1 2025.